AstraZeneca to publish full U.S. trial results after rare rebuke over ‘outdated’ data, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The rare public rebuke marks the latest setback for the vaccine once hailed as a milestone in the fight against the Covid-19 pandemic that has since been dogged by questions over its effectiveness and possible side effects., The rare public rebuke marks the latest setback for the vaccine once hailed as a milestone in the fight against the Covid-19 pandemic that has since been dogged by questions over its effectiveness and possible side effects., , Read More